Correspondence on ‘Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence’-Reference-Cited by-同舟云学术

Correspondence on ‘Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence’

Published:2020-10-01 Issue: Volume: Page:annrheumdis-2020-218921
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Zhang Zheng-Liang,Huang Wei,Lv Guo-Hua,Li Jing,Zou Ming-Xiang^ORCID,Dai Zhi-Hui

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference13 articles.

1. Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence;Koo;Ann Rheum Dis,2020

2. Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis

3. Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: A systematic review and meta-analysis

4. The effect of TNF inhibition on bone density and fracture risk and of il17 inhibition on radiographic progression and bone density in patients with axial spondyloarthritis: a systematic literature review;Ashany;Curr Rheumatol Rep,2019

5. Long-Term treatment with TNF-alpha inhibitors improves bone mineral density but not vertebral fracture progression in ankylosing spondylitis;Beek;J Bone Miner Res,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to ‘Correspondence on “Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence” by Zhanget al;Annals of the Rheumatic Diseases;2020-10-01